Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Unicycive Therapeutics (UNCY)

Annual Return

Over the past 3 years, UNCY has had an average annual return of -19.71%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Jul 12, 2021, UNCY has had an average annual return of -32.69%, underperforming the benchmark SPY, which returned +13.29% annual.

202620252024202320222021
+24.78%-27.33%-8.47%+60.65%-73.79%-58.80%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+3.47%+16.08%-5.05%+16.41%-3.66%-2.44%+24.78%
2025-22.67%-10.34%+4.45%+13.30%-10.05%-18.60%-9.01%-3.46%+4.06%+8.94%+36.21%-10.82%-27.33%
2024+9.51%+45.26%-0%-18.84%-21.43%-43.07%-12.77%-22.65%+20.71%+31.13%+28.79%+15.24%-8.47%
2023+3.70%-7.68%+306.19%-38.10%+2.69%-4.12%-8.59%-34.79%+12.71%-33.66%-11.92%+72.64%+60.65%
2022-33.01%+0.72%-7.19%-32.52%+2.24%-6.74%-10.84%-5.41%-15.71%+16.95%+3.19%-24.16%-73.79%
2021-44.80%+5.07%-2.41%+2.12%-25.95%-3.74%-58.80%

Drawdown analysis of Unicycive Therapeutics (UNCY)

The maximum drawdown for the UNCY was -95.97%, occurring on Aug 13, 2024. This drawdown has not yet recovered.

The current UNCY drawdown is -87.69%.

Since Jul 12, 2021 UNCY has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-95.97%Jul 13, 2021776Aug 13, 2024OngoingOngoingOngoing